Two dichloric compounds inhibit in vivo U87 xenograft tumor growth.
Ontology highlight
ABSTRACT: Dichloroacetate (DCA) is an inhibitor of pyruvate dehydrogenase kinase (PDK) that has been shown to reverse the Warburg effect and cause tumor cell death. Clinical research into the anti-cancer activity of DCA revealed high dosage requirements and reports of toxicity. While there have been subsequent mechanistic investigations, a search for DCA alternatives could result in a safer and more effective anticancer therapy. This study evaluates eight small compounds with a conserved dichloric terminal and their in vitro and in vivo potential for anticancer activity. Initial viability screening across six cancer cell lines reveals even at 10 mg/mL, compound treatments do not result in complete cell death which suggests minimal compound cytotoxicity. Furthermore, in vivo data demonstrates that ca
SUBMITTER: Ovcharenko D
PROVIDER: S-EPMC6741578 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA